Dunad Therapeutics
PrivateLast Round
Strategic
Nov 2, 2021
Total Funding Raised
$30.9M
Company Overview
Dunad Therapeutics is a biotechnology company that develops next-generation targeted oral protein degradation therapies for oncology and CNS indications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dunad Therapeutics Comparables
Compare Dunad Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RDP Pharma AG | 87% | |
| Plexium | 86% | |
| Amphista Therapeutics | 85% | |
Dunad Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 2, 2021 | ||||
| Seed | Mar 23, 2021 |
Dunad Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Epidarex Capital | Strategic, Seed |
| BioGeneration Ventures | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 4, 2025
Monthly visitors increased 52% MoM.
- Oct 22, 2023
Grew 24% QoQ, from 25 to 31 employees.
Dunad Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dunad Therapeutics's valuation, stock price, and market status.